The problem is they continue to promote this procedure and doctors perform it without releasing critical information about it's actual safety and efficacy. This puts patient health at risk. If they worry about releasing the results for whatever reason including potentially mediocre clinical results they should never have done a trial. more regulation is coming soon to stem cell therapy field and it can't come soon enough. And UCLA should do the right thing he and release the results themselves of the company won't
News 
Market Data 
Discover 
